Aimei Health Technology (NASDAQ:AFJK) Issues Earnings Results

Posted by George Bondi on Jun 16th, 2026

Aimei Health Technology (NASDAQ:AFJK – Get Free Report) posted its quarterly earnings data on Tuesday. The company reported $0.01 earnings per share for the quarter, FiscalAI reports.

Aimei Health Technology Trading Down 3.0%

AFJK stock traded down $1.00 during mid-day trading on Tuesday, reaching $32.01. The company’s stock had a trading volume of 550 shares, compared to its average volume of 19,693. The company has a market cap of $101.47 million, a price-to-earnings ratio of 177.83 and a beta of 0.23. The business’s 50 day moving average price is $41.44 and its 200 day moving average price is $40.71. Aimei Health Technology has a 12 month low of $6.75 and a 12 month high of $130.37.

Wall Street Analyst Weigh In

Separately, Weiss Ratings restated a “sell (d+)” rating on shares of Aimei Health Technology in a research report on Friday, March 27th. One research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock has a consensus rating of “Sell”.

Check Out Our Latest Research Report on AFJK

Institutional Investors Weigh In On Aimei Health Technology

Several hedge funds and other institutional investors have recently modified their holdings of AFJK. Berkley W R Corp increased its holdings in shares of Aimei Health Technology by 5.9% during the third quarter. Berkley W R Corp now owns 450,655 shares of the company’s stock valued at $5,101,000 after acquiring an additional 25,294 shares in the last quarter. Clear Street Group Inc. bought a new stake in shares of Aimei Health Technology during the third quarter valued at approximately $691,000. Quarry LP increased its holdings in shares of Aimei Health Technology by 6.4% during the third quarter. Quarry LP now owns 167,081 shares of the company’s stock valued at $1,891,000 after acquiring an additional 10,000 shares in the last quarter. Dakota Wealth Management bought a new stake in shares of Aimei Health Technology during the fourth quarter valued at approximately $406,000. Finally, Geode Capital Management LLC bought a new stake in shares of Aimei Health Technology during the fourth quarter valued at approximately $413,000. Institutional investors own 45.58% of the company’s stock.

About Aimei Health Technology

(Get Free Report)

Aimei Health Technology Co, Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. It intends to acquires businesses in the biopharmaceutical, medical technology/device industries or diagnostic, and other services sectors. Aimei Health Technology Co, Ltd was incorporated in 2023 and is based in New York, New York.